When study site contributes to outcomes in a multi-center randomized trial: a secondary analysis of decisional conflict in men with localized prostate cancer (Article begins on next page) The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters. Citation Underhill, Meghan L, Fangxin Hong, and Donna L Berry. 2014. “When study site contributes to outcomes in a multi-center randomized trial: a secondary analysis of decisional conflict in men with localized prostate cancer. ” Health and Quality of Lif
(Article begins on next page) The Harvard community has made this article openly available. Please s...
(Article begins on next page) The Harvard community has made this article openly available. Please s...
prospective cohort study (Article begins on next page) The Harvard community has made this article o...
prospective study of plasma inflammatory markers and risk of colorectal cancer in men (Article begin...
receptor functions in prostate cancer development and progression (Article begins on next page) The ...
A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer (Art...
to manage analyses and publications in a phase III multicenter randomized clinical trial (Article be...
Time to disease-related pain and first opioid use in patients with metastatic castration-resistant p...
drives poor outcome in high grade serous ovarian cancers and basal-like breast tumors (Article begin...
of prostate cancer in a population-based cohort of men with coeliac disease (Article begins on next ...
of proteomic biomarkers predicting prostate cancer aggressiveness and lethality despite biopsy-sampl...
cancer: clinical outcomes from a National Patient Registry (Article begins on next page) The Harvard...
diseases and their risk factors: Findings of a multicenter study (Article begins on next page) The H...
metastasis and tumourigenesis (Article begins on next page) The Harvard community has made this arti...
phosphoinositide 3-kinase pathway and therapy resistance in cancer (Article begins on next page) The...
(Article begins on next page) The Harvard community has made this article openly available. Please s...
(Article begins on next page) The Harvard community has made this article openly available. Please s...
prospective cohort study (Article begins on next page) The Harvard community has made this article o...
prospective study of plasma inflammatory markers and risk of colorectal cancer in men (Article begin...
receptor functions in prostate cancer development and progression (Article begins on next page) The ...
A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer (Art...
to manage analyses and publications in a phase III multicenter randomized clinical trial (Article be...
Time to disease-related pain and first opioid use in patients with metastatic castration-resistant p...
drives poor outcome in high grade serous ovarian cancers and basal-like breast tumors (Article begin...
of prostate cancer in a population-based cohort of men with coeliac disease (Article begins on next ...
of proteomic biomarkers predicting prostate cancer aggressiveness and lethality despite biopsy-sampl...
cancer: clinical outcomes from a National Patient Registry (Article begins on next page) The Harvard...
diseases and their risk factors: Findings of a multicenter study (Article begins on next page) The H...
metastasis and tumourigenesis (Article begins on next page) The Harvard community has made this arti...
phosphoinositide 3-kinase pathway and therapy resistance in cancer (Article begins on next page) The...
(Article begins on next page) The Harvard community has made this article openly available. Please s...
(Article begins on next page) The Harvard community has made this article openly available. Please s...
prospective cohort study (Article begins on next page) The Harvard community has made this article o...